期刊文献+

心律失常的“上游治疗” 被引量:1

The Upstream Treatment for Arrhythmia
下载PDF
导出
摘要 在心律失常的药物治疗中,抗心律失常药物虽然有效,但并不理想,且很多不良反应和并发症让人难以接受。如何使心律失常患者得到安全、有效的药物治疗,是人们长久以来探索的方向。现已发现,针对高血压、冠心病、心力衰竭等疾病的药物治疗能有效预防或减少心律失常的发生,达到心律失常治疗的一级或二级预防作用,且不良反应相对较少。为此,人们提出心律失常"上游治疗"的新概念。 Drug therapy is common in the treatment of arrhythmias.However,it can have unintended side effects and complications.The lack of consistent results using drug therapy makes the search for more effective therapies a priority.Upsteam therapy is one possible solution.Upstream therapy targets the remodeling of the arrhythmic substrate in order to prevent the formation of abnormalities during remodeling that would cause arrhythmias.
出处 《心血管病学进展》 CAS 2012年第3期304-307,共4页 Advances in Cardiovascular Diseases
关键词 心律失常 上游治疗 arrhythmia upstream therapy
  • 相关文献

参考文献15

  • 1JCS Joint Working Group. Guidelines tbr pharmacotherapy of atrial fibrillation (JCS 2008) : digest version[J]. Circ J,2010,74( 11 ) :2479-2500.
  • 2Schneider MP, Hua TA, Buhm M, et al. Prevention of atrial fibrillation by re-nin-angiotensin system inhibition: a meta-analysis [ J ]. J Am Coll Cardiol, 20 ! 0,55 ( 21 ) : 2299-2307.
  • 3GISSI-AF Investigators, Disertori M, Latini R, et al. Valsartan for prevention of recurrent atrial fibrillation[J]. N Engl J Med,2009,360(16) :1606-1617.
  • 4ACTIVE I Investigators, Yusuf S, Healey JS, et al. Irbesartan in patients with atrial fibrillation[J]. N Engl J Med,2011,364(10) :928-938.
  • 5Gopinathannair R, Chaudhary AK, Xing D, et al. Angiotensin II effects on is- chemic focal ventricular tachycardia are predominantly mediated through myocar- dial AT(2) receptor[J]. Am J Physiol Heart Circ Physiol,2009,297(5) : H1889-H1898.
  • 6Wang LX, Ideishi M, Yahiro E, et al. Mechanism of the cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury[ J]. Hypertens Res,2001,24(2) : 179-187.
  • 7Yue TL, Wang C, Gu JL, et al. Inhibition of extracellular signal-regulated ki- nase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart[ J]. Circ Res,2000,86 ( 6 ) :692-699.
  • 8Young-Xu Y, Jabbour S, Goldberg R, et al. Usefulness of statin drugs in pro- tecting against atrial fibrillation in patients with coronary artery disease [ J ]. Am J Cardiol,2003,92(12) :1379-1383.
  • 9Hanna IR, Heeke B, Bush H, et al. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction [ J ]. Heart Rhythm,2006,3 ( 8 ) : 881-886.
  • 10Siu CW, Lau CP, Tse HF. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion [ J ]. Am J Cardiol,2003,92 ( 11 ) : 1343-1345.

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部